Atrovent Hfa Generic Name & Formulations
Legal Class
Rx
General Description
Ipratropium bromide 17micrograms/inh; metered dose inhaler; CFC-free.
Pharmacological Class
Anticholinergic.
How Supplied
Inhaler—12.9g (200 inh); inhalation soln—contact supplier
Manufacturer
Generic Availability
HFA (NO); soln (YES)
Atrovent Hfa Indications
Indications
Bronchospasm associated with chronic bronchitis and emphysema.
Atrovent Hfa Dosage and Administration
Adult
2 inh 4 times daily; max 12 inh/day.
Children
Not established.
Atrovent Hfa Contraindications
Contraindications
Allergy to atropine or its derivatives.
Atrovent Hfa Boxed Warnings
Not Applicable
Atrovent Hfa Warnings/Precautions
Warnings/Precautions
Not for primary treatment of acute attack. Avoid eyes. Narrow-angle glaucoma. GU obstruction. Pregnancy. Nursing mothers.
Atrovent Hfa Pharmacokinetics
See Literature
Atrovent Hfa Interactions
Interactions
Caution with other anticholinergics.
Atrovent Hfa Adverse Reactions
Adverse Reactions
Bronchitis, COPD exacerbation, dyspnea, headache, anticholinergic effects; paradoxical bronchospasm, hypersensitivity reactions.
Atrovent Hfa Clinical Trials
See Literature
Atrovent Hfa Note
Not Applicable
Atrovent Hfa Patient Counseling
See Literature